系统性红斑性狼和COVID-19的情况
Maria Pappa1, Alexandros Panagiotopoulos1, Konstantinos Thomas2
11st Department of Propaedeutic Internal Medicine, Medical School National and Kapodistrian University of Athens, Athens, Greece.
对于全身性红斑狼 (SLE) 患者来说,COVID-19疫苗接种是安全有效的,尽管像Rituximab这样的免疫抑制药物可能会影响免疫反应并增加COVID-19的严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 传染性疾病 传染性疾病
背景情况:
- 系统性红斑狼 (SLE) 是一种影响多个器官的自身免疫性疾病.
- 了解COVID-19对SLE患者的影响对于在疫情期间管理他们的健康至关重要.
研究的目的:
- 审查有关SLE患者COVID-19的当前知识.
- 评估SARS-CoV-2疫苗的接种率,免疫性和SLE的安全性.
- 为了确定SLE中不良COVID-19结果的风险因素.
主要方法:
- 关于COVID-19和SLE研究的文献综述.
- 对疫苗数据的分析 (吸收,免疫性,安全性).
- 评估SLE患者的COVID-19结果和危险因素.
主要成果:
- 对于SLE患者来说,COVID-19疫苗是安全的.
- 幽默性免疫性通常可以实现,但可以通过免疫抑制剂,特别是rituximab来降低.
- 利图西马布的使用与更糟糕的COVID-19结果有关,包括住院和死亡.
结论:
- 虽然接种疫苗可以改善结果,但服用免疫抑制剂的SLE患者需要谨慎管理.
- 免疫抑制药物仍然是缓解COVID-19对SLE患者影响的关键挑战.
- 需要继续进行研究,以优化这一群体的COVID-19预防和治疗.
更多相关视频
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
